The cream which is used to treat skin diseases like eczema, dematitis and allergies, has annual US sales of USD 34 million, according to IMS Health sales data for the 12 months period ending June 2013.
Glenmark Pharmaceuticals' USA unit has entered into a royalty-bearing license agreement with Triax Pharmaceuticals, Astellas Pharma Europe BV and Astellas Pharma International BV to settle last year's patent infringement suit against the comercialisation of generic version of Locoid Lipocream, the company said in a press release Wednesday.